Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Severe Respiratory Infections”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT05578391
What this trial is testing

Passive Immunotherapy In Patients With SARS CoV-2

Who this might be right for
COVID-19
Fundacin Biomedica Galicia Sur 61
Testing effectiveness (Phase 2)UnknownNCT04389580
What this trial is testing

Combination Therapy With Isotretinoin and Tamoxifen Expected to Provide Complete Protection Against Severe Acute Respiratory Syndrome Coronavirus

Who this might be right for
COVID-19
Kafrelsheikh University 160
Early research (Phase 1)Study completedNCT00006368
What this trial is testing

Yttrium Y 90 SMT 487 in Treating Patients With Refractory or Recurrent Cancer

Who this might be right for
Brain and Central Nervous System TumorsBreast CancerGastrointestinal Carcinoid Tumor+5 more
Novartis Pharmaceuticals 60
Not applicableUnknownNCT04627623
What this trial is testing

Prevalence and Risk Factors of COVID-19 in the Upper Silesian Agglomeration

Who this might be right for
Covid19Respiratory Tract InfectionsSevere Acute Respiratory Syndrome+4 more
Medical University of Silesia 6,000
Testing effectiveness (Phase 2)Study completedNCT04402060
What this trial is testing

APL-9 in Adults With Mild to Moderate ARDS Due to COVID-19

Who this might be right for
COVIDCovid-19Coronavirus+6 more
Apellis Pharmaceuticals, Inc. 72
Not applicableUnknownNCT05452759
What this trial is testing

Research of Spiral Exhalation Device Oxygen Therapy to Improve the Treatment Effect of Patients With Severe Pneumonia

Who this might be right for
Pneumonia
Shenzhen Second People's Hospital 156
Large-scale testing (Phase 3)Ended earlyNCT05639192
What this trial is testing

Asunercept for the Treatment of Patients With Moderate to Severe COVID-19 Disease

Who this might be right for
COVID-19
Apogenix GmbH 34
Testing effectiveness (Phase 2)UnknownNCT04920760
What this trial is testing

Vitamin A Supplementation in Children With Moderate to Severe COVID-19

Who this might be right for
Covid19
Shiraz University of Medical Sciences 60
Not applicableStudy completedNCT04967781
What this trial is testing

Autoimmunity Contributes to the Severe Progression of COVID-19

Who this might be right for
Coronavirus Disease 2019
Zhongnan Hospital 162
Early research (Phase 1)Study completedNCT04461353
What this trial is testing

Evaluate the Safety, Tolerability and Pharmacokinetics of Orally Inhaled Aerosolized Hydroxychloroquine Sulfate in Healthy Adult Volunteers

Who this might be right for
Severe Acute Respiratory Syndrome Coronavirus 2
Pulmoquine Therapeutics, Inc 12
Not applicableStudy completedNCT04567836
What this trial is testing

Screening of Health-care Workers in an University Hospital for SARS-CoV-2

Who this might be right for
Covid19
University of Milano Bicocca 260
Not applicableStudy completedNCT04380779
What this trial is testing

Prevalence of Severe Bleeding in COVID-19 Patients Treated With Higher Than Recommended Thromboprophylaxis Doses

Who this might be right for
COVID-19
Manuel Monreal 2,430
Not applicableStudy completedNCT03641690
What this trial is testing

Serum and Bronchoalveolar Inflammatory Parameters in Patients With Severe Adult Respiratory Distress Syndrome

Who this might be right for
H1N1 Influenza
Centre Hospitalier Universitaire, Amiens 97
Large-scale testing (Phase 3)Looking for participantsNCT06653569
What this trial is testing

Efficacy of Baloxavir Against Influenza in Hospitalized Patients: The INFLUENT Study (INpatients inFLUENza Treatment)

Who this might be right for
Influenza Disease; Flu
Dre Pauline Vetter 484
Post-approval studies (Phase 4)Ended earlyNCT05102162
What this trial is testing

BL Infusion Trial:Beta-lactam Continuous Versus Intermittent Infusion and Associated Bacterial Resistance and Therapy Outcomes in Critically Ill Patients With Severe Pneumonia

Who this might be right for
Pneumonia
University of Florida 35
Large-scale testing (Phase 3)UnknownNCT04802382
What this trial is testing

Clinical Study Designed to Evaluate the Effect of CimetrA in Patients Diagnosed With COVID-19

Who this might be right for
Corona Virus InfectionCovid19SARS-CoV Infection
MGC Pharmaceuticals d.o.o 252
Testing effectiveness (Phase 2)Study completedNCT04961541
What this trial is testing

Evaluation of the Safety and Immunogenicity of Influenza and COVID-19 Combination Vaccine

Who this might be right for
SARS-CoV InfectionCovid19
Novavax 637
Not applicableNot Yet RecruitingNCT07828327
What this trial is testing

Real-World Effectiveness of Depemokimab in Allergic Bronchopulmonary Aspergillosis With Severe Eosinophilic Asthma

Who this might be right for
Allergic Bronchopulmonary AspergillosisABPASevere Eosinophilic Asthma
Qianfoshan Hospital 10
Early research (Phase 1)Study completedNCT05181683
What this trial is testing

COVID-19 Study Assessing the Safety and Tolerability of Co-Formulated Anti-Spike (S) SARS-CoV-2 Monoclonal Antibodies (Casirivimab+Imdevimab) in Adult Volunteers

Who this might be right for
HealthyChronic Stable Illness
Regeneron Pharmaceuticals 45
Testing effectiveness (Phase 2)Study completedNCT04712110
What this trial is testing

TAK-019 in Healthy Japanese Adults (COVID-19)

Who this might be right for
Prevention of Infection Disease Caused by Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2)
Takeda 200
Next Page